Biotechnology stocks with a focus on the US market

Top holdings (2024/03/28)
ISIN Name Currency %FA
- VERTEX PHARMAC. DL-,01 - 7.73%
- GILEAD SCIENCES DL-,001 - 7.50%
- BIOGEN INC. DL -,0005 - 5.13%
- AMGEN INC. DL-,0001 - 4.65%
- BIOMARIN PHAR. DL-,001 - 2.99%
- ARGENS SE SP.ADR/1 -,10 - 2.65%
- MADRIGAL PHARMAC. DL-,01 - 2.50%
- SAREPTA THERAP. DL-,0001 - 2.14%
Holdings by country (2024/03/28)
85.30% United States of America
8.50% United Kingdom
2.92% Netherlands
1.09% Denmark
Percentage holdings by sector (2024/03/28)
83.63% Biotechnology
12.83% Pharmaceuticals
2.96% Life Sciences Tools & Services
0.59% Health Care Services
Holdings by currency (2024/03/28)
103.20% USD
-3.20% EUR
The full names of the open-ended mutual funds and complete product information are provided in the statutes (prospectuses) of the funds. The information stated herein is of the nature of a promotional message. The information stated in this message is not an investment recommendation or investment advice since it does not take into account the specific situation of specific investors. The value of the financial instruments may rise and fall, while there is no guarantee of a return on the originally invested amount. Past performance is no guarantee of the same performance in a future period. A visitor to this website may be outside the target market of the financial instruments stated herein. We recommend that you consult your specific investment plan with an expert advisor who will verify that the planned investment will be commensurate with your knowledge and experience, that it will be in accordance with your needs, characteristics and goals, financial circumstances or relation to risk, and will familiarise you with all possible risks of a specific investment opportunity.